Lv2
118 积分 2026-03-05 加入
Characterization and treatment outcomes of rituximab therapy in super-responders and rituximab-refractory pemphigus patients: A single-center retrospective study
24天前
已完结
Assessment of anti-desmoglein antibodies levels and other laboratory indexes as objective comprehensive indicators of patients with pemphigus vulgaris of different severity: a single-center retrospective study
24天前
已完结
Ultralow‐dose rituximab in pemphigus: a single‐centre experience
2个月前
已完结
Prognostic value of glim criteria in patients with BCLC stage B or C hepatocellular carcinoma who underwent systemic therapy
3个月前
已关闭
Risk of malignancies and all-cause mortality in patients with pemphigus: A longitudinal cohort study
3个月前
已完结
Risk of malignancies and all-cause mortality in patients with pemphigus: A longitudinal cohort study
3个月前
已关闭
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy
3个月前
已完结
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors
3个月前
已完结
Clinical observation of different doses of rituximab for the treatment of severe pemphigus: A single-center prospective cohort study
3个月前
已完结
皖公网安备34019202002308
